Hypothesis
Oral administration of anxiety-reducing Lactobacillus strains (e.g., L. rhamnosus JB-1, L. plantarum LZU-J-TSL6) increases heart rate variability (HRV) through a vagal-dependent pathway that originates in the enteric nervous system (ENS) via serotonergic signaling from enterochromaffin cells. This HRV increase mediates the observed reduction in anxiety-like behavior, and blocking vagal afferent signaling or 5‑HT₃ receptors will abolish both the HRV shift and the anxiolytic effect.
Mechanistic Rationale
The ENS integrates microbial signals and communicates with the brain chiefly through the vagus nerve [ENS as a central mediator in microbiota-gut-brain communication]. Lactobacillus metabolites (e.g., lactate, tryptophan derivatives) stimulate enterochromaffin cells to release serotonin (5‑HT) [L. rhamnosus JB-1 reduces anxiety via vagal pathways; LZU-J-TSL6 increases hippocampal GABA and BDNF]. Released 5‑HT activates 5‑HT₃ receptors on vagal afferent fibers in the gut wall, increasing afferent firing to the nucleus tractus solitarius (NTS). Enhanced NTS activity boosts parasympathetic outflow, raising HRV, particularly in the high‑frequency (HF) band that reflects respiratory‑linked vagal tone. Improved vagal tone then dampens amygdala‑centric fear circuits, lowering anxiety scores [L. rhamnosus significantly reduces anxiety-like behavior].
This mec





























